URELLE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Meda Pharmaceuticals. The primary component is Hyoscyamine Sulfate; Methenamine; Methylene Blue; Phenyl Salicylate; Sodium Phosphate, Monobasic, Monohydrate.
| Product ID | 0037-6321_3c4ac6f5-f382-4cf7-aa0d-87959fa0c705 |
| NDC | 0037-6321 |
| Product Type | Human Prescription Drug |
| Proprietary Name | URELLE |
| Generic Name | Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, And Sodium Phosphate, Monobasic, Monohydrate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-01-12 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Meda Pharmaceuticals |
| Substance Name | HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Active Ingredient Strength | 0 mg/1; mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | Oxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2015-01-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | Unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-12 |
| Ingredient | Strength |
|---|---|
| HYOSCYAMINE SULFATE | .12 mg/1 |
| SPL SET ID: | 1d80a11c-6f86-403b-85d4-32ec1924dbe9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() URELLE 85481729 4220875 Dead/Cancelled |
DSM IP Assets B.V. 2011-11-28 |
![]() URELLE 77860362 3806629 Live/Registered |
MEDA PHARMA S.A.R.L. 2009-10-29 |
![]() URELLE 76405748 2697669 Dead/Cancelled |
AZUR PHARMA INTERNATIONAL II LIMITED 2002-05-10 |